New prospects for innovation in the Health sector in Greece
The Minister of Health, Adonis Georgiadis, recently referred to the challenges and opportunities facing the Greek healthcare system. During the 16th "Future of Healthcare" conference, the Minister emphasized the importance of strengthening innovation, despite the difficulties caused by the high clawback.
Clawback is the amount that pharmaceutical companies return to the state when pharmaceutical expenditure exceeds the budget. Despite the fact that this issue remains a significant financial burden for the industry, Mr. Georgiadis underlined that the government has managed to create the necessary fiscal space to support new treatments.
The goal of the political leadership is to facilitate the access of Greek patients to modern and innovative medicines. This effort requires a balance between the control of public spending and the need for the continuous evolution of pharmaceutical care in the country.
The conference provided an opportunity for dialogue between health stakeholders and the state. Participants discussed the future of the system and solutions that can improve the quality of services provided to citizens.
The discussion on clawback and innovation remains at the center of interest for Greek society. The government declares its determination to continue reforms, with the aim of a more sustainable and effective healthcare system for all.